Who actually wins and loses from the Google remedies

Digiday's stakeholder rundown splits the outcome cleanly. The quiet winners are rival exchanges (Index Exchange, PubMatic, OpenX get real-time bid access to AdX through Prebid), Prebid itself (which becomes the load-bearing pipe to Google's demand), and large, resourced publishers (who can act on the data). The losers: the DOJ, which lost nearly every fight over strictness and speed but did secure a second antitrust order against Google in two years; and CTV, in-app and retail media publishers, who get nothing because the whole judgment stops at open-web display. Adform CTO Jochen Schlosser framed it: "Regulating auction access while leaving that buy-side integration intact doesn't open the market, it just turns Google into a supervised public utility and sets up a six-year game of algorithmic hide-and-seek." OpenX, by contrast, said in a statement it is "encouraged by the behavioral remedies" and will press its civil damages case. NYU Stern adjunct professor Scott Schiller put the sharpest point on it: "The bigger question is whether a remedy focused on open-web display is solving yesterday's market while advertising is rapidly moving toward CTV, retail media and AI."

The crux

The remedy fixes the part of the market that is shrinking (open-web display, where Google's own AdWords impressions fell from over 40% to 11% between 2019 and 2025) while leaving the fast-growing CTV, in-app and retail media segments untouched, so the biggest publishers gain a data right over a shrinking asset.

Sell-side read

If you are a large open-web publisher with technical chops, this is a genuine data handover and a fairer auction; if your inventory skews CTV or retail media, the biggest antitrust ruling in a decade does nothing for you.

Watch

Whether European regulators read this as proof behavioural remedies work, or as a green light to push the structural breakup the DOJ failed to win.